Labat AfricaFRA:LAO EV-to-FCF is 9.50 as of Jul. 11, 2026, which is 105% above its 10-year median of 4.64. The stock has 5 warning signs investors should review. Among 562 Drug Manufacturers companies, Labat Africa ranks better than 80.6% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Labat Africa's Enterprise Value is €12.70 Mil.
Labat Africa's Free Cash Flow for the trailing twelve months (TTM) ended in Nov. 2025 was €1.34 Mil. Therefore, Labat Africa's EV-to-FCF for today is 9.50.
The historical rank and industry rank for Labat Africa's EV-to-FCF or its related term are showing as below:
FRA:LAO'
s EV-to-FCF Range Over the Past 10 Years
Min: -38.51 Med: 4.64 Max: 251.31
Current: 9.08
During the past 13 years, the highest EV-to-FCF of Labat Africa was 251.31. The lowest was -38.51. And the median was 4.64.
FRA:LAO's EV-to-FCF is ranked better than 80.6% of 562
companies
in the Drug Manufacturers industry
Industry Median: 20.765
vs FRA:LAO: 9.08
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Labat Africa's PE Ratio (TTM) for today is calculated as:
Labat Africa's share price for today is €0.001.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Labat Africa's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Nov. 2025 was €0.007.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Labat Africa EV-to-FCF Related Terms
Labat Africa EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Labat Africa's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Labat Africa's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labat Africa EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Labat Africa's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Labat Africa's EV-to-FCF falls into.
Labat Africa's current Enterprise Value is €12.70 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Labat Africa's Free Cash Flow for the trailing twelve months (TTM) ended in Nov. 2025 was €1.34 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Labat Africa (FRA:LAO) has a EV-to-FCF of 9.50 as of Jul. 11, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Labat Africa and its competitors. This is 105% above median its historical median of 4.64. According to the industry distribution chart, Labat Africa ranks #109 out of 562 companies in the Drug Manufacturers industry, placing it in the top 19.4%.
Is Labat Africa's EV-to-FCF too high?
Labat Africa's current EV-to-FCF of 9.50 is 105% above median its 10-year median of 4.64. The Drug Manufacturers industry median EV-to-FCF is 20.77. Labat Africa's value of 9.50 is 54.2% below this industry median. Based on the distribution chart, Labat Africa ranks #109 out of 562 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Labat Africa's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Labat Africa ranks #109 out of 562 companies for EV-to-FCF. This places Labat Africa in the top 19% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 20.77. Labat Africa's value of 9.50 is 54.2% below this benchmark. While the company's 10-year median is 4.64 vs. the industry median of 20.77, Labat Africa has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.77, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Labat Africa's current EV-to-FCF of 9.50 is 54.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Labat Africa and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labat Africa's current EV-to-FCF is 9.50, which is 105% above median its own 10-year median of 4.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labat Africa stock overvalued right now?
Labat Africa (FRA:LAO) has a current EV-to-FCF of 9.50. The stock's GF Value™ is €0.01, compared to a current price of €0.00 — trading 90% below its estimated fair value. The current EV-to-FCF is 9.50, which is 105% above median its 10-year median of 4.64 and 54.2% below the Drug Manufacturers industry median of 20.77. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Labat Africa (FRA:LAO), the current EV-to-FCF is 9.50 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Labat Africa Ltd is an investment holding company. Through its subsidiaries, the company operates in the following segments; Technology, Head office, and Healthcare. The Technology segment manufactures and distributes integrated circuits South African Micro - Electronic Systems. Head office operations provide management services, logistics and seeks further investment opportunities for the Group. The Healthcare segment generates maximum revenue for the company and focusses on medical cannabis industry in South Africa. Geographically, the company carries out its business operations in South Africa.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:LAO has been successfully added to your 